Sun Pharmaceutical shares on Tuesday fell over 16 per cent as they witnessed massive selling pressure after the drug major said it expects to take a hit on profit for the fiscal due to charges related to the ongoing integration with Ranbaxy Laboratories. Reacting to this, shares of the company opened the day on a weak note and lost further to 15.6 per cent to Rs 799.05 at BSE. On the NSE, the stock dipped 16.11 per cent to Rs 795.25. The stock was the top loser among the stocks on key indices Sensex and Nifty. The drug major has said on Monday that it expects to take a hit on profit for the fiscal due to the charges related to the ongoing integration with Ranbaxy Laboratories. Also, the company may look to discontinue certain non-strategic businesses, it said. As per the company's estimates, the consolidated revenues would remain flat or show a decline over FY15.
About Money99
Parag Patil is a technical analyst and trading system designer with stock excel programmer. I hope the articles and live chart of nse future and mcx on this Website will be as helpful and profitable to you . I try to update and post new articles tips everyday. My motto is to encourage the traders, so that they should able to understand the technique views behind the moment of stocks. I have deeply analyzed with many technical indicator with parameter and added to my amibroker afl. And even taken backtest report which is never being implemented. Any of the analyst expect me. Seeing all this you may understand that my views is more technical than commercial. If you are profited by my views I fill happy.
0 comentários:
Post a Comment